Tirzepatide 10 mg is a ≥ 99 % pure dual-receptor peptide supplied as a lyophilized
powder forÂ
in-vitro GLP-1 / GIP research. For laboratory use only—no human
or veterinary applications.
Tirzepatide is a synthetic peptideÂ
under investigation for concurrent
agonist activity atÂ
GLP-1Â and
GIPÂ receptors.
OngoingÂ
in-vitro studies explore dual-receptor signalling pathways
relevant to metabolic research models.
Specification
- Peptide Name:Â Tirzepatide
- Content:Â 10 mg lyophilized powder (requires reconstitution)
- Purity: ≥ 99 % (HPLC / MS certificate available)
- Manufacturing:Â ISO 9001:2015 & cGMP-audited facility
- Intended Use:Â In-vitro laboratory research only
Storage & Handling
- Prior to reconstitution: store ≤ 8 °C in a dry environment
- After reconstitution: refrigerate 2 – 8 °C and use within 30 days
- For extended preservation: aliquot and freeze at −20 °C
- Avoid repeated freeze–thaw cycles
Compliance Notice
Supplied exclusively to qualified professionals for controlled laboratory
applications. No dosage or administration guidance is provided. Buyer assumes
responsibility for safe handling and regulatory adherence.
$95.00
Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg)
1 × $175.00